From the publishers of The New England Journal of Medicine

Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.

  1. Home>
  2. Specialties>
  3. Pediatrics and Adolescent Medicine>
  4. Summary and Comment

Oseltamivir Prevents Complications of Influenza in High-Risk Children

Oseltamivir prescribed within 1 day of clinical diagnosis of influenza reduced risks for complications and hospitalization in children with chronic conditions.

In a manufacturer-sponsored study, investigators examined the effects of oseltamivir on influenza-related complications in children with chronic diseases. Using an administrative claims database, the investigators compared outcomes in 1634 children who received an oseltamivir prescription within 1 day of influenza diagnosis and 3721 children who did not receive antiviral therapy after influenza diagnosis. All children (age range, 1–17 years) were considered to be at high risk for complications because of a chronic disease (including HIV/AIDS, asthma, cancer) and received diagnoses of influenza between the 2000 and 2006 flu seasons.

During the 14 days after influenza diagnosis, children who received oseltamivir were less likely than those who did not receive oseltamivir to be hospitalized (0.6% vs. 1.3%) and to have pneumonia (1.0% vs. 1.9%), a respiratory illness other than pneumonia (19.8% vs. 23.8%), and otitis media (2.8% vs. 4.9%). In analyses adjusting for potential confounders, all these differences were statistically significant except for the difference in pneumonia outcomes. Results were similar 30 days after diagnosis.

Comment: This study is an excellent example of comparative effectiveness research. Using observational data, these investigators found that oseltamivir prevents complications of influenza in high-risk children. These children were not infected with the novel H1N1 ("swine flu") virus. However, readers should note that the FDA has granted emergency approval for the use of oseltamivir for treatment or prevention of 2009 influenza A (H1N1) in adults and children — including those younger than 1 year. For specific information, visit the CDC website.

Howard Bauchner, MD

Published in Journal Watch Pediatrics and Adolescent Medicine August 5, 2009

Citation(s):

Piedra PA et al. Effects of oseltamivir on influenza-related complications in children with chronic medical conditions. Pediatrics 2009 Jul; 124:170.

Reader Remarks:

Review and add to remarks on this article

Your Remark:

Reader Remarks are intended to encourage lively discussion of clinical topics with your peers in the medical community. We ask that you keep your remarks to a reasonable length, and we reserve the right to withhold publication of remarks that do not meet this standard.

The editors of Journal Watch may respond to Reader Remarks, but we cannot promise to respond to a particular remark.

Fields marked with an * are required.

Name as you'd like it to appear:

Submitting a comment indicates you have read and agreed to the remark guidelines and declare:*

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

 

CLEAR erases anything you've added in any part of the form. CONTINUE allows you to check your entire post (and edit it if necessary) before submitting.

To ensure that your Reader Remark is not formatted as one long paragraph, precede new paragraphs with either a blank line or an indentation.

Search

Advanced

Related Content

Sign-In

Forgot your password? Login via Athens
or your institution

New to Journal Watch?

E-mail Alerts

Delivered to your inbox.
Tailored to your interests. Free.

Sign Up Now!

Journal Watch Newsletters

Available in 13 specialties with convenient delivery and 10 free online CME exams.

Subscribe Now!

Copyright © 2009. Massachusetts Medical Society. All rights reserved.